Currently Enrolling
Trial Physician / Study Coordinator
Akinwande Akinfolarin
EmailSite Name
Renal Disease Research Inst.
411 N. Washington Ave. Dallas, Texas, 75246 (United States)
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
320
Estimated End Date
December 2025